ORBIMED ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (CRBP)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
OrbiMed Capital LLC
Security
Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share
Symbol
CRBP
Shares outstanding
12,172,881 shares
Disclosed Ownership
718,200 shares
Ownership
5.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:30:03 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 5.9% ownership in Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (CRBP) on 31 Dec 2024."

Quick Takeaways

  • ORBIMED ADVISORS LLC filed SCHEDULE 13G/A for Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (CRBP).
  • Disclosed ownership: 5.9%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
OrbiMed Advisors LLC 3.7% 454,087 0 454,087 /s/ Carl L. Gordon Carl L. Gordon/Member
OrbiMed Capital LLC 5.9% 718,200 718,200 0 /s/ Carl L. Gordon Carl L. Gordon/Member

Sponsored